Bridget Wagner

Bridget Wagner leads research groups in identifying small molecules for diabetes therapy at Arena BioWorks and has a background in biochemistry from Harvard University. Prior to their current role, Bridget held various positions at the Broad Institute of MIT and Harvard, focusing on pancreatic cell biology and chemical biology.